EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
EAHP is increasingly being asked by different stakeholders if we are planning on publishing new shortages data. Our 2014 Shortages Report is being cited in every presentation given in Brussels on shortages.
The Bulgarian Council Presidency will focus on the following points:
The last point is the most interesting for EAHP, since it would give us an opportunity to discuss our views on shortages with Bulgaria. I would suggest to the Board to consider approaching Bulgaria in relation to shortages. It needs to be decided what we would like to achieve with a meeting with the Bulgarian presidency.
In December 2017, Medicines for Europe organised an event in the European Parliament on “Patient access to medicines: how to prevent medicine shortages?”. The session was chaired by MEP Lieve Wierinck and attended by 1 other MEP (Cristian-SilviuBusoi). MEP Andreas Schwab did not make it in the end. Panellists included Agnès Mathieu (COM), Marc-Alexander Mahl (Medicines for Europe), Ortwin Schulte (Health Attaché, German Permanent Representation), Eddy Gilissen (IQVIA), Vlad Voiculescu (Member of Romanian Health Observatory, Romania), Elfi de Weerdt (PhD medicine shortages, COST member).
Presentation HERE
Agenda HERE
Briefing HERE
Medicines for Europe position paper HERE
On 16th January 2017 the JP and RP met with Medicines for Europe to discuss perspectives on the problem of medicines shortages as related to shortages in generic medicine. Discussion naturally turned to procurement-related shortages, and impacts of certain kinds of generic tendering. A conclusion of the meeting was to explore a further, larger meeting bring together procurement specialist hospital pharmacists and MfE representatives to see if any useful shared conclusions could be drawn for preventing and mitigating shortages in the generic sector. SK picked up on this suggestion. RM provided SK with the contacts of procurement specialist hospital pharmacists after the Congress in Cannes. This information was shared with Medicines for Europe. The responsible policy officer – Catarina Lopes Pereira – requested a meeting with EAHP and Medicines for Europe to discuss the possibility of a “workshop”. A conference call was organised on 14th July 2017. During this meeting EAHP clarified that a “workshop” – if it is discussed – should not be built on the assumption that procurement/ generic tendering is linked to shortages. The “workshop” should rather try to identify causes of shortages and if generic tendering is a cause this could be discussed.
A follow up session in late August 2017/ September 2017 was not organised since Catarina Lopes Pereira did not manage to contact her members in time. SK drafted a concept note for a workshop based on the discussion in July 2017 (concept note is available HERE). AB suggested to discuss this outline as well as the general idea of holding a workshop with Medicines for Europe on shortages with the Board.
SK briefly spoke to one of the chairs of the task force (Kristin Raudsepp, Director General, Estonian State Agency of Medicines). Ms Raudseep indicated that the task force is currently still “finding” itself. However, the members have already discussed the possibility to reach out to stakeholders. This mainly concerns industry, however she highlighted that the views of hospital pharmacists and other healthcare professionals could also be of importance and consequently be considered by the task force. A concrete timeline for this outreach activity has however not been set yet. Provided that we are planning specific actions in the area of medicines shortages, I would suggested to keep Ms Raudseep informed about them.
The COST Head of Science Operations has informed the members of COST Action 15105 on 20th January 2018 that a non-compliance procedure has been triggered (notification email HERE). This procedure concerns the chair of COST Action 15105, Prof Helena Jenzer and the disregard of instructions by COST.
